1.
Int Forum Allergy Rhinol
; 13(12): 2248-2251, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37317899
RESUMO
KEY POINTS: Patients treated with pembrolizumab experience an increase in paranasal sinus inflammation Use of topical triamcinolone in carboxymethylcellulose is a treatment option for such patients.